Cannabinoid Use and Abuse, and Cannabinoid Hyperemesis Syndrome
TOC Will Appear Here
This article is available to subscribers.
Already have an account? Log in. Not a subscriber? Subscribe now.

Cannabinoids: Emerging Evidence in Use and Abuse (Pharmacology CME)

Cannabinoids: Emerging Evidence in Use and Abuse (Pharmacology CME)

Already purchased this course?
Log in to read.
Purchase a subscription

Price: $449/year

140+ Credits!

Purchase Issue & CME Test

Price: $75

+4 Credits!

Money-back Guarantee
Publication Information

Mollie V. Williams, MD

Peer Reviewed By

Joseph Habboushe, MD, MBA; Nadia Maria Shaukat, MD, RDMS, FACEP

Publication Date

August 1, 2018

CME Expiration Date

August 31, 2021

CME Credits

4 AMA PRA Category 1 Credits™, 4 ACEP Category I Credits, 4 AAFP Prescribed Credits, 4 AOA Category 2-A or 2-B Credits.
Specialty CME Credits: Included as part of the 4 credits, this CME activity is eligible for 1 Behavioral Health CME and 3 Pharmacology CME credits

Get Permission

CME Information

Related Articles

Synthetic Drug Intoxication in Children: Recognition and Management in the Emergency Department - Pediatric Emergency Medicine Practice - May 2018

Get A Sample Issue Of Emergency Medicine Practice
Enter your email to get your copy today! Plus receive updates on EB Medicine every month.
Please provide a valid email address.